Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle
Experimental Physiology · 2024-02 · 109 (2) · 175-189
DOI: 10.1113/ep090436 ↗At a glance
Übersichtsarbeit in Experimental Physiology, published online on 2023-12-14. Written by Yiangos Psaras and 1 co-authors. Institution: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Major MEDLINE topics: Muscle, Skeletal, Muscular Dystrophy, Duchenne. Cited 3 times so far (Crossref); 108 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust.
Abstract (original language)
Skeletal myopathies and ataxias with secondary cardiac involvement are complex, progressive and debilitating conditions. As life expectancy increases across these conditions, cardiac involvement often becomes more prominent. This highlights the need for targeted therapies that address these evolving cardiac pathologies. Musculopathies by and large lack cures that directly target the genetic basis of the diseases; however, as our understanding of the genetic causes of these conditions has evolved, it has become tractable to develop targeted therapies using biologics, to design precision approaches to target the primary genetic causes of these varied diseases. Using the examples of Duchenne muscular dystrophy, Friedreich ataxia and Pompe disease, we discuss how the genetic causes of such diseases derail diverse homeostatic, energetic and signalling pathways, which span multiple cellular systems in varied tissues across the body. We outline existing therapeutics and treatments in the context of emerging novel genetic approaches. We discuss the hurdles that the field must overcome to deliver targeted therapies across the many tissue types affected in primary myopathies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
ORCID profiles: Christopher N Toepfer
Funding
- Wellcome Trust
Cite
APA
Psaras, Y., & Toepfer, C. N. (2024). Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle. Experimental Physiology, 109(2), 175-189. https://doi.org/10.1113/ep090436
Vancouver
Psaras Y, Toepfer CN. Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle. Experimental Physiology. 2024;109(2):175-189. doi:10.1113/ep090436
BibTeX
@article{Psaras2024,
author = {Psaras, Yiangos and Toepfer, Christopher N},
title = {Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle},
journal = {Experimental Physiology},
year = {2024},
volume = {109},
number = {2},
pages = {175--189},
doi = {10.1113/ep090436}
}
EUVIMED